Literature DB >> 10869286

Short- and long-term outcome of severe alcohol-induced hepatitis treated with steroids or enteral nutrition: a multicenter randomized trial.

E Cabré, P Rodríguez-Iglesias, J Caballería, J C Quer, J L Sánchez-Lombraña, A Parés, M Papo, R Planas, M A Gassull.   

Abstract

Steroids are recommended in severe alcohol-induced hepatitis, but some data suggest that artificial nutrition could also be effective. We conducted a randomized trial comparing the short- and long-term effects of total enteral nutrition or steroids in these patients. A total of 71 patients (80% cirrhotic) were randomized to receive 40 mg/d prednisolone (n = 36) or enteral tube feeding (2,000 kcal/d) for 28 days (n = 35), and were followed for 1 year or until death. Side effects of treatment occurred in 5 patients on steroids and 10 on enteral nutrition (not significant). Eight enterally fed patients were prematurely withdrawn from the trial. Mortality during treatment was similar in both groups (9 of 36 vs. 11 of 35, intention-to-treat) but occurred earlier with enteral feeding (median 7 vs. 23 days; P =.025). Mortality during follow-up was higher with steroids (10 of 27 vs. 2 of 24 intention-to-treat; P =. 04). Seven steroid patients died within the first 1.5 months of follow-up. In contrast to total enteral nutrition (TEN), infections accounted for 9 of 10 follow-up deaths in the steroid group. In conclusion, enteral feeding does not seem to be worse than steroids in the short-term treatment of severe alcohol-induced hepatitis, although death occurs earlier with enteral nutrition. However, steroid therapy is associated with a higher mortality rate in the immediate weeks after treatment, mainly because of infections. A possible synergistic effect of both treatments should be investigated.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10869286     DOI: 10.1053/jhep.2000.8627

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  73 in total

Review 1.  Nutritional support for liver disease.

Authors:  Ronald L Koretz; Alison Avenell; Timothy O Lipman
Journal:  Cochrane Database Syst Rev       Date:  2012-05-16

2.  Prevalence of septic events, type 1 hepatorenal syndrome, and mortality in severe alcoholic hepatitis and utility of discriminant function and MELD score in predicting these adverse events.

Authors:  Sumita Verma; Ketan Ajudia; Michel Mendler; Allan Redeker
Journal:  Dig Dis Sci       Date:  2006-08-22       Impact factor: 3.199

Review 3.  Alcoholic liver disease and malnutrition.

Authors:  Craig J McClain; Shirish S Barve; Ashutosh Barve; Luis Marsano
Journal:  Alcohol Clin Exp Res       Date:  2011-02-01       Impact factor: 3.455

4.  ESPEN guideline on clinical nutrition in liver disease.

Authors:  Mathias Plauth; William Bernal; Srinivasan Dasarathy; Manuela Merli; Lindsay D Plank; Tatjana Schütz; Stephan C Bischoff
Journal:  Clin Nutr       Date:  2019-01-16       Impact factor: 7.324

5.  General aspects of the treatment of alcoholic hepatitis.

Authors:  Michael J Babineaux; Bhupinderjit S Anand
Journal:  World J Hepatol       Date:  2011-05-27

Review 6.  Neurological complications post-liver transplantation: impact of nutritional status.

Authors:  Chantal Bemeur
Journal:  Metab Brain Dis       Date:  2012-11-06       Impact factor: 3.584

7.  A meta-analysis of nutritional supplementation for management of hospitalized alcoholic hepatitis.

Authors:  Ramy Antar; Phil Wong; Peter Ghali
Journal:  Can J Gastroenterol       Date:  2012-07       Impact factor: 3.522

8.  Early enteral nutrition, provided within 24 h of injury or intensive care unit admission, significantly reduces mortality in critically ill patients: a meta-analysis of randomised controlled trials.

Authors:  Gordon S Doig; Philippa T Heighes; Fiona Simpson; Elizabeth A Sweetman; Andrew R Davies
Journal:  Intensive Care Med       Date:  2009-09-24       Impact factor: 17.440

Review 9.  EASL Clinical Practice Guidelines on nutrition in chronic liver disease.

Authors: 
Journal:  J Hepatol       Date:  2018-08-23       Impact factor: 25.083

Review 10.  Advances in alcoholic liver disease: An update on alcoholic hepatitis.

Authors:  Randy Liang; Andy Liu; Ryan B Perumpail; Robert J Wong; Aijaz Ahmed
Journal:  World J Gastroenterol       Date:  2015-11-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.